摘要
Gastrin-releasing peptide (GRP) binds to its receptor (GRP receptor [GRPR]) to regulate multiple biological processes, but the function of GRP/GRPR axis in acute kidney injury (AKI) remains unknown. In the present study, GRPR is highly expressed by tubular epithelial cells (TECs) in patients or mice with AKI, while histone deacetylase 8 may lead to the transcriptional activation of GRPR. Functionally, we uncovered that GRPR was pathogenic in AKI, as genetic deletion of GRPR was able to protect mice from cisplatin-and ischemia-induced AKI. This was further confirmed by specifically deleting the GRPR gene from TECs in GRPRFlox/Flox//KspCre mice. Mechanistically, we uncovered that GRPR was able to interact with Toll -like receptor 4 to activate STAT1 that bound the promoter of MLKL and CCL2 to induce TEC necroptosis, necroinflammation, and macrophages recruitment. This was further confirmed by overexpressing STAT1 to restore renal injury in GRPRFlox/Flox/KspCre mice. Concurrently, STAT1 induced GRP synthesis to enforce the GRP/GRPR/STAT1 positive feedback loop. Importantly, targeting GRPR by lentivirus-packaged small hairpin RNA or by treatment with a novel GRPR antagonist RH-1402 was able to inhibit cisplatin-induced AKI. In conclusion, GRPR is pathogenic in AKI and mediates AKI via the STAT1-dependent mechanism. Thus, targeting GRPR may be a novel therapeutic strategy for AKI.
学科与关键词
- Discovery of a novel GRPR antagonist for protection against cisplatin-induced acute kidney injuryYu, Ming-jun; Li, Chao; Deng, Sheng-song; Meng, Xiao-ming; Yao, Ri-sheng*Bioorganic Chemistry, 2022, 124: 105794.被引 2
- Neat1 promotes acute kidney injury to chronic kidney disease by facilitating tubular epithelial cells apoptosis via sequestering miR-129-5pMa, Tongtong; Li, Hongwei; Liu, Hui; Peng, Yili; Lin, Tong; Deng, Zhiya; Jia, Nan; Chen, Zhongqing; Wang, Peng*Molecular Therapy, 2022, 30(10): 3313-3332.被引 12
- RP105 protects against ischemic and septic acute kidney injury via suppressing TLR4/NF-κB signaling pathwaysZhu, Jiefu; Zhang, Yafei; Shi, Lang; Xia, Yao; Zha, Hongchu; Li, Huimin; Song, Zhixia*International Immunopharmacology, 2022, 109.被引 7
